3D-Printed Retinal Tissue Reinforcement for ECM Hydrogel Stability

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current treatments for age-related macular degeneration (AMD), particularly geographic atrophy (GA), are limited in their ability to restore vision and require engineering of a triple-layer tissue including choriocapillaris, RPE, and photoreceptors, with challenges in maintaining distinct identities and functions of different cell types in co-culture systems.

Innovation Solution

A method involving 3D printing of a cellularized retinal construct using endothelial cells, RPE cells, and photoreceptors within an ECM hydrogel, reinforced by a biocompatible small-molecule agent that chemically interacts with the ECM to increase its compressive modulus, forming a stable and functional retina-like structure.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If a triple-layer tissue structure (choriocapillaris/RPE/photoreceptors) is engineered to treat AMD, then the functional restoration capability is improved, but the complexity of maintaining distinct cell identities and functions in co-culture increases

Engineering Contradiction:
Improvefunctional restoration capabilityVSAvoidcomplexity of maintaining distinct cell identities
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The retinal tissue is segmented into three distinct layers (choriocapillaris, RPE, and photoreceptors), with each layer containing specific cell types that maintain their distinct identities. The 3D printing process deposits cells layer-by-layer, allowing each cell type to be cultured and maintained separately while forming part of the integrated triple-layer structure.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

Different regions of the construct have specialized properties tailored to specific cell types. The choriocapillaris layer receives vascular factors, the RPE layer receives pigmentation factors, and the photoreceptor layer receives photoprotection factors. This localized quality control ensures each cell type maintains its distinct function within the co-culture system.

Inventive Principle:
Principle #3Local quality

2Ease of manufacture

If RPE and photoreceptor cells are co-cultured with different culture media and supplements, then the growth and differentiation of each cell type is supported, but the process complexity increases

Engineering Contradiction:
Improvegrowth and differentiation supportVSAvoidprocess complexity
Core Design Contradiction:
Ease of manufactureVSDevice complexity

Solution Approach 1:

Cells are pre-differentiated and pre-cultured in their respective specialized media before being deposited into the 3D construct. Endothelial cells are pre-cultured with vascular factors, RPE cells with pigmentation factors, and photoreceptors with photoprotection factors. This preliminary action allows each cell type to establish its identity before integration, simplifying the overall co-culture process.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The ECM hydrogel serves as an intermediary matrix that facilitates the co-culture of different cell types. The hydrogel provides a common structural framework that supports all three cell types while allowing them to maintain their distinct culture requirements. The hydrogel matrix mediates the interaction between layers and enables nutrient and factor diffusion throughout the construct.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Strength

If the ECM hydrogel is reinforced with a small-molecule crosslinking agent, then the structural integrity and compressive modulus are improved, but the potential impact on cell viability increases

Engineering Contradiction:
Improvecompressive modulusVSAvoidimpact on cell viability
Core Design Contradiction:
StrengthVSObject-affected harmful factors

Solution Approach 1:

The crosslinking process parameters are carefully controlled to achieve the desired compressive modulus while maintaining cell viability. The small-molecule crosslinking agent is applied at optimized concentrations and incubation times, allowing the ECM hydrogel to gain structural strength without exposing cells to harmful levels of chemical agents. The process parameters are tuned to balance reinforcement with biocompatibility.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The reinforced retinal construct provides a stable, functional structure that can be implanted to potentially attenuate and regenerate damaged retinas, addressing the limitations of existing treatments by enhancing structural integrity and cellular interaction.

Implementation Method 1

contacting the cellularized retinal construct with a biocompatible small-molecule reinforcing agent that is capable of chemically interacting with the ECM hydrogel under conditions that maintain viability of the cells, to thereby increase a compressive modulus of the ECM hydrogel

Methodology Applied
Scientific EffectChemical cross-linking: Chemical Bonding

Data Source

PatentUS20250367348A13D printing of 3-layered retina and choroid tissue
Publication Date: 2025.12.04 ICHILOV TECH LTD
  • US20250367348A1 patent drawing
  • US20250367348A1 patent drawing
  • US20250367348A1 patent drawing

AI summary

A method for reinforcing a cellularized retinal construct fabricated from (i) endothelial cells; (ii) retinal pigment epithelial cells and/or photoreceptors; and (iii) an extracellular matrix (ECM) hydrogel is disclosed. The method comprises contacting the construct with a biocompatible small-molecule reinforcing agent that is capable of chemically interacting with the ECM hydrogel under conditions that maintain viability of the cells, to thereby increase a compressive modulus of the ECM hydrogel by at least 10%.